Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175041 · ClinicalTrials.gov registry record · NA

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT04175041: Active NA study of Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

NCT04175041 is a NA study of Attention Deficit Hyperactivity Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 104 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04175041, a NA study of Attention Deficit Hyperactivity Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

To determine the cognitive and neurophysiological dose-response relationships of anodal tDCS to the left DLPFC as a function of absolute current intensity, individualized E-field intensity, and stimulation duration.

Primary Outcome

Measured using Eriksen Flanker Task (EFT)

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2019-07-09
Est. Completion 2026-05
Phase NA
Massachusetts General Hospital

2,032 total trials

What the registry record for NCT04175041 still lists

NCT04175041 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT04175041 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04175041 about?

NCT04175041 is a clinical study titled "A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC". To determine the cognitive and neurophysiological dose-response relationships of anodal tDCS to the left DLPFC as a function of absolute current intensity, individualized E-field intensity, and stimulation duration.

What is the current status of trial NCT04175041?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2019-07-09. Estimated completion is 2026-05.

What conditions does trial NCT04175041 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT04175041?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04175041?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04175041 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04175041's enrollment target sits among peer trials

104 46th of 102 higher than 57 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04175041, the US trial registry maintained by the National Library of Medicine. NCT04175041 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.